Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Reported Sunday, Ascentage Pharma Announces FDA And EMA Clearance Of Global Registrational Phase III GLORA-4 Study of Lisaftoclax Plus Azacitidine For First-Line Treatment Of Higher-Risk Myelodysplastic Syndrome

Author: Benzinga Newsdesk | August 18, 2025 01:17am

Posted In: AAPG